Non-O157 Shiga Toxin-Producing E. coli Infections in Europe
Author Information
Author(s): Alfredo Caprioli, Alberto E. Tozzi, Gianfranco Rizzoni, Helge Karch
Primary Institution: Istituto Superiore di Sanita, Rome, Italy
Hypothesis
Non-O157 STEC may pose an underestimated threat to public health.
Conclusion
Non-O157 STEC infections are significant and often overlooked in clinical settings.
Supporting Evidence
- Non-O157 STEC infections have caused 10% to 30% of sporadic HUS cases in Europe.
- STEC O103 and O26 infections increased significantly in 1996.
- Two patients developed HUS from non-O157 STEC infections.
Takeaway
Some germs that can make people very sick aren't the usual ones doctors look for, so we need to check for them more carefully.
Methodology
Analysis of HUS cases and laboratory identification of non-O157 STEC.
Potential Biases
There is a risk of bias due to the underreporting of non-O157 STEC infections in clinical laboratories.
Limitations
The study is limited by the reliance on standard microbiologic detection methods that may miss non-O157 STEC.
Participant Demographics
Patients with hemolytic uremic syndrome in Germany and Italy.
Want to read the original?
Access the complete publication on the publisher's website